Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

A detailed analysis in the Canadian Journal of Cardiology of the cost-effectiveness of semaglutide shows that with price reductions, it could meet the benchmark for healthcare value, urging ...

FILE PHOTO: A handout photo shows a nine-month supply of Novo Nordisk's diabetes drug Ozempic stored in a refrigerator in London (Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for ...

Discover the revolutionary needle-free weight-loss pill orforglipron, often referred to as 'Ozempic 2.0'. Learn how it ...

The Therapeutic Goods Administration (TGA) has warned patients taking GLP-1 weight loss and diabetes jabs should be monitored for suicidal behaviour.

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

(Reuters) -Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic ...